Beans Beneficial for Patients With History of Colorectal Neoplasia
By Elana Gotkine HealthDay Reporter
TUESDAY, Dec. 26, 2023 -- Adding a cup of beans to the usual diet enhances the gut microbiome and regulates host markers associated with metabolic obesity and colorectal cancer, according to a study published in the December issue of eBioMedicine.
Xiaotao Zhang, M.D., Ph.D., from The University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a low-risk, noninvasive dietary intervention targeting the gut microbiota of obese surveillance patients with a history of colorectal neoplasia. After a four-week equilibrium, 55 patients were randomly assigned to continue their usual diet without beans or to add a daily cup of study beans to their usual diet, with immediate crossover at eight weeks.
The researchers found that 87 percent of patients completed the 16-week trial, which demonstrated an increase in diversity and shifts in multiple bacteria indicative of prebiotic efficacy on intervention, including increased Faecalibacterium, Eubacterium, and Bifidobacterium. Parallel shifts were seen in nutrient and microbiome-derived metabolites in the circulating metabolome, including increased pipecolic acid and decreased indole; upon returning to the usual diet, these shifts regressed. Within eight weeks, there were no significant changes seen in circulating lipoproteins; however, there were increases observed in proteomic biomarkers of intestinal and systemic inflammatory response and fibroblast-growth factor-19 and a decrease in interleukin-10 receptor-α.
"Adding one cup of navy beans to the diet on all or most days of the week was a safe, scalable dietary strategy to modulate the gut microbiome of high-risk patients, who may be unwilling or unable to sustain more dramatic changes to their usual dietary pattern without substantial support," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.